Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Conformationally supple glucose monomers enable synthesis of the smallest cyclodextrins.

Ikuta D, Hirata Y, Wakamori S, Shimada H, Tomabechi Y, Kawasaki Y, Ikeuchi K, Hagimori T, Matsumoto S, Yamada H.

Science. 2019 May 17;364(6441):674-677. doi: 10.1126/science.aaw3053. Epub 2019 Apr 11. Erratum in: Science. 2019 May 17;364(6441):.

PMID:
30975766
2.

Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum.

Gotoh A, Katoh T, Sakanaka M, Ling Y, Yamada C, Asakuma S, Urashima T, Tomabechi Y, Katayama-Ikegami A, Kurihara S, Yamamoto K, Harata G, He F, Hirose J, Kitaoka M, Okuda S, Katayama T.

Sci Rep. 2018 Sep 18;8(1):13958. doi: 10.1038/s41598-018-32080-3.

3.

Slow luminescence kinetics of semi-synthetic aequorin: expression, purification and structure determination of cf3-aequorin.

Inouye S, Tomabechi Y, Hosoya T, Sekine SI, Shirouzu M.

J Biochem. 2018 Sep 1;164(3):247-255. doi: 10.1093/jb/mvy049.

PMID:
29796619
4.

Phosphorylated and non-phosphorylated HCK kinase domains produced by cell-free protein expression.

Katsura K, Tomabechi Y, Matsuda T, Yonemochi M, Mikuni J, Ohsawa N, Terada T, Yokoyama S, Kukimoto-Niino M, Takemoto C, Shirouzu M.

Protein Expr Purif. 2018 Oct;150:92-99. doi: 10.1016/j.pep.2018.05.005. Epub 2018 May 21.

PMID:
29793032
5.

Microbial production of novel sulphated alkaloids for drug discovery.

Matsumura E, Nakagawa A, Tomabechi Y, Ikushiro S, Sakaki T, Katayama T, Yamamoto K, Kumagai H, Sato F, Minami H.

Sci Rep. 2018 May 22;8(1):7980. doi: 10.1038/s41598-018-26306-7.

6.

Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors.

Koda Y, Kikuzato K, Mikuni J, Tanaka A, Yuki H, Honma T, Tomabechi Y, Kukimoto-Niino M, Shirouzu M, Shirai F, Koyama H.

Bioorg Med Chem Lett. 2017 Nov 15;27(22):4994-4998. doi: 10.1016/j.bmcl.2017.10.012. Epub 2017 Oct 7.

PMID:
29037944
7.

A reproducible and scalable procedure for preparing bacterial extracts for cell-free protein synthesis.

Katsura K, Matsuda T, Tomabechi Y, Yonemochi M, Hanada K, Ohsawa N, Sakamoto K, Takemoto C, Shirouzu M.

J Biochem. 2017 Nov 1;162(5):357-369. doi: 10.1093/jb/mvx039.

PMID:
28992119
8.

Structural basis for CRMP2-induced axonal microtubule formation.

Niwa S, Nakamura F, Tomabechi Y, Aoki M, Shigematsu H, Matsumoto T, Yamagata A, Fukai S, Hirokawa N, Goshima Y, Shirouzu M, Nitta R.

Sci Rep. 2017 Sep 6;7(1):10681. doi: 10.1038/s41598-017-11031-4.

9.

Identification and characterization of a sulfoglycosidase from Bifidobacterium bifidum implicated in mucin glycan utilization.

Katoh T, Maeshibu T, Kikkawa KI, Gotoh A, Tomabechi Y, Nakamura M, Liao WH, Yamaguchi M, Ashida H, Yamamoto K, Katayama T.

Biosci Biotechnol Biochem. 2017 Oct;81(10):2018-2027. doi: 10.1080/09168451.2017.1361810. Epub 2017 Aug 17.

PMID:
28814130
10.

Extra-adrenal glucocorticoids contribute to the postprandial increase of circulating leptin in mice.

Tomabechi Y, Tsuruta T, Saito S, Wabitsch M, Sonoyama K.

J Cell Commun Signal. 2018 Jun;12(2):433-439. doi: 10.1007/s12079-017-0403-9. Epub 2017 Jul 25.

11.

Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen.

Yuki H, Kikuzato K, Koda Y, Mikuni J, Tomabechi Y, Kukimoto-Niino M, Tanaka A, Shirai F, Shirouzu M, Koyama H, Honma T.

Bioorg Med Chem. 2017 Aug 15;25(16):4259-4264. doi: 10.1016/j.bmc.2017.05.053. Epub 2017 Jun 16.

PMID:
28662963
12.

Structural characterization of the immunostimulatory exopolysaccharide produced by Leuconostoc mesenteroides strain NTM048.

Matsuzaki C, Takagaki C, Tomabechi Y, Forsberg LS, Heiss C, Azadi P, Matsumoto K, Katoh T, Hosomi K, Kunisawa J, Yamamoto K, Hisa K.

Carbohydr Res. 2017 Aug 7;448:95-102. doi: 10.1016/j.carres.2017.06.004. Epub 2017 Jun 15.

PMID:
28633071
13.

Chemo-enzymatic synthesis of a glycosylated peptide containing a complex N-glycan based on unprotected oligosaccharides by using DMT-MM and Endo-M.

Tomabechi Y, Katoh T, Kunishima M, Inazu T, Yamamoto K.

Glycoconj J. 2017 Aug;34(4):481-487. doi: 10.1007/s10719-017-9770-y. Epub 2017 May 18.

PMID:
28523604
14.

Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.

Katoh T, Katayama T, Tomabechi Y, Nishikawa Y, Kumada J, Matsuzaki Y, Yamamoto K.

J Biol Chem. 2016 Oct 28;291(44):23305-23317. Epub 2016 Sep 14.

15.

Laboratory-scale production of (S)-reticuline, an important intermediate of benzylisoquinoline alkaloids, using a bacterial-based method.

Matsumura E, Nakagawa A, Tomabechi Y, Koyanagi T, Kumagai H, Yamamoto K, Katayama T, Sato F, Minami H.

Biosci Biotechnol Biochem. 2017 Feb;81(2):396-402. doi: 10.1080/09168451.2016.1243985. Epub 2016 Oct 14.

PMID:
27740901
16.

Lysosome-associated membrane proteins-1 and -2 (LAMP-1 and LAMP-2) assemble via distinct modes.

Terasawa K, Tomabechi Y, Ikeda M, Ehara H, Kukimoto-Niino M, Wakiyama M, Podyma-Inoue KA, Rajapakshe AR, Watabe T, Shirouzu M, Hara-Yokoyama M.

Biochem Biophys Res Commun. 2016 Oct 21;479(3):489-495. doi: 10.1016/j.bbrc.2016.09.093. Epub 2016 Sep 20.

PMID:
27663661
17.

Crystal structure of nanoKAZ: The mutated 19 kDa component of Oplophorus luciferase catalyzing the bioluminescent reaction with coelenterazine.

Tomabechi Y, Hosoya T, Ehara H, Sekine SI, Shirouzu M, Inouye S.

Biochem Biophys Res Commun. 2016 Jan 29;470(1):88-93. doi: 10.1016/j.bbrc.2015.12.123. Epub 2015 Dec 30.

PMID:
26746005
18.

Convergent chemo-enzymatic synthesis of mannosylated glycopeptides; targeting of putative vaccine candidates to antigen presenting cells.

McIntosh JD, Brimble MA, Brooks AES, Dunbar PR, Kowalczyk R, Tomabechi Y, Fairbanks AJ.

Chem Sci. 2015 Aug 1;6(8):4636-4642. doi: 10.1039/c5sc00952a. Epub 2015 May 19.

19.

Protein stabilization utilizing a redefined codon.

Ohtake K, Yamaguchi A, Mukai T, Kashimura H, Hirano N, Haruki M, Kohashi S, Yamagishi K, Murayama K, Tomabechi Y, Itagaki T, Akasaka R, Kawazoe M, Takemoto C, Shirouzu M, Yokoyama S, Sakamoto K.

Sci Rep. 2015 May 18;5:9762. doi: 10.1038/srep09762.

20.

Direct thiophenylation accompanying orthoester-cleavage of 1,2,4-O-orthoacetyl-3,6-O-(o-xylylene)glucopyranose.

Uchino T, Tomabechi Y, Fukumoto A, Yamada H.

Carbohydr Res. 2015 Jan 30;402:118-23. doi: 10.1016/j.carres.2014.10.004. Epub 2014 Oct 20.

PMID:
25498011
21.

Crystal structures of the S6K1 kinase domain in complexes with inhibitors.

Niwa H, Mikuni J, Sasaki S, Tomabechi Y, Honda K, Ikeda M, Ohsawa N, Wakiyama M, Handa N, Shirouzu M, Honma T, Tanaka A, Yokoyama S.

J Struct Funct Genomics. 2014 Sep;15(3):153-64. doi: 10.1007/s10969-014-9188-8. Epub 2014 Jul 31.

22.

Convergent chemoenzymatic synthesis of a library of glycosylated analogues of pramlintide: structure-activity relationships for amylin receptor agonism.

Kowalczyk R, Brimble MA, Tomabechi Y, Fairbanks AJ, Fletcher M, Hay DL.

Org Biomol Chem. 2014 Nov 7;12(41):8142-51. doi: 10.1039/c4ob01208a. Epub 2014 Jul 17.

PMID:
25030939
23.

Kinase crystal identification and ATP-competitive inhibitor screening using the fluorescent ligand SKF86002.

Parker LJ, Taruya S, Tsuganezawa K, Ogawa N, Mikuni J, Honda K, Tomabechi Y, Handa N, Shirouzu M, Yokoyama S, Tanaka A.

Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):392-404. doi: 10.1107/S1399004713028654. Epub 2014 Jan 29.

PMID:
24531473
24.

Endo-β-N-acetylglucosaminidase catalysed glycosylation: tolerance of enzymes to structural variation of the glycosyl amino acid acceptor.

Tomabechi Y, Squire MA, Fairbanks AJ.

Org Biomol Chem. 2014 Feb 14;12(6):942-55. doi: 10.1039/c3ob42104j.

PMID:
24362939
25.

Glycosylation of pramlintide: synthetic glycopeptides that display in vitro and in vivo activities as amylin receptor agonists.

Tomabechi Y, Krippner G, Rendle PM, Squire MA, Fairbanks AJ.

Chemistry. 2013 Nov 4;19(45):15084-8. doi: 10.1002/chem.201303303. Epub 2013 Oct 7. No abstract available.

PMID:
24123422
26.

A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo.

Saito Y, Yuki H, Kuratani M, Hashizume Y, Takagi S, Honma T, Tanaka A, Shirouzu M, Mikuni J, Handa N, Ogahara I, Sone A, Najima Y, Tomabechi Y, Wakiyama M, Uchida N, Tomizawa-Murasawa M, Kaneko A, Tanaka S, Suzuki N, Kajita H, Aoki Y, Ohara O, Shultz LD, Fukami T, Goto T, Taniguchi S, Yokoyama S, Ishikawa F.

Sci Transl Med. 2013 Apr 17;5(181):181ra52. doi: 10.1126/scitranslmed.3004387.

27.

Structures of histone methyltransferase SET7/9 in complexes with adenosylmethionine derivatives.

Niwa H, Handa N, Tomabechi Y, Honda K, Toyama M, Ohsawa N, Shirouzu M, Kagechika H, Hirano T, Umehara T, Yokoyama S.

Acta Crystallogr D Biol Crystallogr. 2013 Apr;69(Pt 4):595-602. doi: 10.1107/S0907444912052092. Epub 2013 Mar 14.

PMID:
23519668
28.

Flexibility of the P-loop of Pim-1 kinase: observation of a novel conformation induced by interaction with an inhibitor.

Parker LJ, Watanabe H, Tsuganezawa K, Tomabechi Y, Handa N, Shirouzu M, Yuki H, Honma T, Ogawa N, Nagano T, Yokoyama S, Tanaka A.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Aug 1;68(Pt 8):860-6. doi: 10.1107/S1744309112027108. Epub 2012 Jul 31.

29.

A novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptide.

Tsuganezawa K, Watanabe H, Parker L, Yuki H, Taruya S, Nakagawa Y, Kamei D, Mori M, Ogawa N, Tomabechi Y, Handa N, Honma T, Yokoyama S, Kojima H, Okabe T, Nagano T, Tanaka A.

J Mol Biol. 2012 Mar 30;417(3):240-52. doi: 10.1016/j.jmb.2012.01.036. Epub 2012 Jan 30.

PMID:
22306408
30.

Crystal structures of the armadillo repeat domain of adenomatous polyposis coli and its complex with the tyrosine-rich domain of Sam68.

Morishita EC, Murayama K, Kato-Murayama M, Ishizuka-Katsura Y, Tomabechi Y, Hayashi T, Terada T, Handa N, Shirouzu M, Akiyama T, Yokoyama S.

Structure. 2011 Oct 12;19(10):1496-508. doi: 10.1016/j.str.2011.07.013. Erratum in: Structure. 2011 Dec 7;19(12):1896.

31.

Crystal structure of the Ca²⁺/calmodulin-dependent protein kinase kinase in complex with the inhibitor STO-609.

Kukimoto-Niino M, Yoshikawa S, Takagi T, Ohsawa N, Tomabechi Y, Terada T, Shirouzu M, Suzuki A, Lee S, Yamauchi T, Okada-Iwabu M, Iwabu M, Kadowaki T, Minokoshi Y, Yokoyama S.

J Biol Chem. 2011 Jun 24;286(25):22570-9. doi: 10.1074/jbc.M111.251710. Epub 2011 Apr 19.

32.

Acceptor specificity in the transglycosylation reaction using Endo-M.

Tomabechi Y, Odate Y, Izumi R, Haneda K, Inazu T.

Carbohydr Res. 2010 Nov 22;345(17):2458-63. doi: 10.1016/j.carres.2010.08.022. Epub 2010 Sep 17.

PMID:
20934176
33.

Chemo-enzymatic synthesis of glycosylated insulin using a GlcNAc tag.

Tomabechi Y, Suzuki R, Haneda K, Inazu T.

Bioorg Med Chem. 2010 Feb;18(3):1259-64. doi: 10.1016/j.bmc.2009.12.031. Epub 2009 Dec 16.

PMID:
20036558
34.

Solution structure of the RNA binding domain in the human muscleblind-like protein 2.

He F, Dang W, Abe C, Tsuda K, Inoue M, Watanabe S, Kobayashi N, Kigawa T, Matsuda T, Yabuki T, Aoki M, Seki E, Harada T, Tomabechi Y, Terada T, Shirouzu M, Tanaka A, Güntert P, Muto Y, Yokoyama S.

Protein Sci. 2009 Jan;18(1):80-91. doi: 10.1002/pro.17.

35.

Preparation of monodisperse SiO2 nanoparticles by membrane emulsification using ideally ordered anodic porous alumina.

Yanagishita T, Tomabechi Y, Nishio K, Masuda H.

Langmuir. 2004 Feb 3;20(3):554-5.

PMID:
15773073
36.

Outcome in one-vessel coronary artery disease.

Califf RM, Tomabechi Y, Lee KL, Phillips H, Pryor DB, Harrell FE Jr, Harris PJ, Peter RH, Behar VS, Kong Y, Rosati RA.

Circulation. 1983 Feb;67(2):283-90.

PMID:
6848217

Supplemental Content

Loading ...
Support Center